Post-transfusion purpura (PTP)
Thrombocytopenia · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Sudden severe thrombocytopenia 5-12 days after a blood transfusion, typically in a previously alloimmunised (parous) woman with anti-HPA-1a antibodies. Self-limiting but can cause life-threatening bleeding; the patient destroys their OWN platelets.
Red flags
- Intracranial or other major bleeding
- Platelets <10
Assessment
Differential diagnosis
- ITP
- Heparin-induced thrombocytopenia
- Drug-induced thrombocytopenia
- DIC
- Dilutional thrombocytopenia (massive transfusion)
- TTP
Investigations
- FBC + film; note timing relative to transfusion (5-12 days)
- HPA (human platelet antigen) antibody testing — anti-HPA-1a (specialist)
- Coagulation screen
- Transfusion history and prior pregnancies
Management
- Recognise severe thrombocytopenia 5-12 days post-transfusion
- First line: IVIG (raises the count over days)
- High-dose corticosteroids
- Plasma exchange if refractory
- AVOID random-donor platelet transfusion (ineffective, may worsen) — use HPA-1a-negative platelets ONLY for life-threatening bleeding
- Tranexamic acid for mucosal bleeding
- Flag for antigen-negative (HPA-1a-negative) blood components for any future transfusion
- Haematology + transfusion medicine
Drugs & doses
IVIG (first-line)
Corticosteroids
HPA-1a-negative platelets (life-threatening bleeding only)
Tranexamic acid
Disposition
Admit; haematology and transfusion-medicine involvement.
Complications & pitfalls
- Fatal haemorrhage (esp. intracranial)
- Recurrence with future transfusion
Exam pearls
- Severe thrombocytopenia ~1 week after transfusion in a parous woman = PTP
- IVIG is first-line, NOT platelet transfusion
- Random-donor platelets do not help — use HPA-1a-negative products
- Flag for antigen-negative components for life
IVIG is first-line. Ordinary platelet transfusions are ineffective and may worsen PTP; reserve HPA-compatible platelets for life-threatening bleeding.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.